drugset / Trial / NCT02215772
Metabolism and Pharmacokinetics of [14C]-BI 44370 BS Administered as an Oral Solution in Healthy Male Volunteers
NaSingle-groupOpen-labelTreatment
Summary
Study to investigate the basic pharmacokinetics of BI 44370 BS, its metabolite CD 10419 BS, and 14C-radioactivity including mass balance, excretion pathways, and metabolism following a single oral administration of 200 mg \[14C\]BI 44370 BS to healthy male volunteers and to evaluate safety and tolerability following a single oral administration of 200 mg \[14C\]BI 44370 BS to healthy male volunteers
Timeline
- Start
- 2008-09
- Primary completion
- 2008-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 44370 | Small molecule | 2.43 mbq | Oral |
| Subject | BI 44370 | Small molecule | 200 mg | Oral |
Indications
No indication recorded.